Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling

  • Gang Cao
  • , Ruyi Zhu
  • , Ting Jiang
  • , Dongxin Tang
  • , Hiu Yee Kwan
  • , Tao Su*
    • *Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

39 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science